Four Federal Efforts to Monitor, Including RESULTS Act Progress
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
Already a member? Log in here
Reimbursement-nir
Subscribe today for access to
Articles and Reports
FDA Watch: New RAPID Coverage Pathway Would Enable Some Lab Tests to Pursue Clearance and Medicare Coverage Simultaneously
FDA-CMS collaboration aims to accelerate Medicare coverage determinations of certain medical devices
Already a member? Log in here
RCM Strategies to Explore for Genetic Testing Compliance
Expert Ashley Zarling details nuances for clinical lab directors and compliance teams
Already a member? Log in here
Medicare to Reimburse 6 New CLIA-Waived Tests, Starting Oct. 1
...
Already a member? Log in here
The Biden Budget: The 9 Things Lab Managers Should Know
...
Already a member? Log in here
OIG Work Plan Targets Medicare Part B Billing & Payment of Lab Tests
...
Already a member? Log in here
CMS Proposes to Ease but Not End Hospital Price Transparency
...
Already a member? Log in here
Ensure Proper Billing of New FDA-Approved CLIA-Waived Tests
...
Already a member? Log in here
CMS Proposes to Ease, but Not End Hospital Price Transparency
...
Already a member? Log in here
MCIT Medicare Coverage Rule Could Be Reimbursement “Breakthrough” for Makers of LDTs
...
Already a member? Log in here
OIG Sounds the Warning on Improper COVID-19 Vaccination Billing
...
Already a member? Log in here
MedPAC Explores Simplified PAMA Reporting to Cut Burdens & Restore Lab Prices
...
Already a member? Log in here